 |
市場調查報告書
商品編碼
1672845
質子幫浦阻斷劑市場按類型、適應症、劑型、通路和地區分類Proton Pump Inhibitors Market, By Type, By Disease Indication, By Dosage Form, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
2025 年全球質子幫浦阻斷劑市場規模估計為 40.2 億美元，預計到 2032 年將達到 59 億美元，2025 年至 2032 年的複合年成長率為 5.6%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 40.2億美元 |
| 效能資料 | 從 2020 年到 2024 年 | 預測期 | 2025 至 2032 年 |
| 預測期：2025-2032年複合年成長率： | 5.60% | 2032 年價值預測 | 59億美元 |
數字。 2025 年質子幫浦阻斷劑各地區市場佔有率（%）
質子幫浦阻斷劑（PPI）是一類透過減少胃酸產生量來發揮作用的藥物。 PPI 通常用於治療胃酸倒流、潰瘍和食道發炎。 PPI 透過抑制質子幫浦（位於胃壁細胞表面的酵素）的活性發揮作用。這種酵素負責運輸有助於胃產生鹽酸的離子。透過抑制此泵，PPI 可以減少酸的產生並緩解胃酸過多的症狀。酸性疾病盛行率上升、患有此類疾病的老齡人口增加以及醫療保健支出上升，可能在不久的將來推動全球質子幫浦阻斷劑市場的成長。
市場動態：
全球消化性潰瘍和胃食道逆流症（GERD）等酸性疾病的盛行率不斷上升，可能會推動全球質子幫浦阻斷劑市場的成長。由於飲食和生活方式的改變，GERD 在世界各地變得非常普遍。據估計，GERD 影響了超過 20％ 的北美人口。質子幫浦阻斷劑是 GERD 患者的首選藥物。老年人口的增加也將推動市場成長，因為老年人更容易罹患酸性相關疾病。然而，長期使用 PPI 的副作用，如腎損傷、骨折、肺炎和營養吸收受損，可能會阻礙市場成長。新興經濟體對消化器官系統健康認知的提高和醫療保健支出的增加可能為市場參與者提供機會。
本研究的主要特點
- 本報告對全球質子幫浦阻斷劑市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。
- 它揭示了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
- 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
- 全球質子幫浦阻斷劑市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
- 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球質子幫浦阻斷劑市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員將透過用於分析全球質子幫浦阻斷劑市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管情景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
4. 全球質子幫浦阻斷劑市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
5. 全球質子幫浦阻斷劑市場，按類型，2020-2032 年（十億美元）
- 奧美拉唑
- 泮他拉唑
- Rabeprazole
- 右旋索拉唑
- 蘭索拉唑
- 其他
6. 2020 年至 2032 年全球質子幫浦阻斷劑市場（依疾病適應症分類）（十億美元）
- 潰瘍
- 胃食道逆流症
- 其他
7. 2020-2032 年全球質子幫浦阻斷劑市場（按劑型分類）（十億美元）
- 錠劑
- 膠囊
- 注射
- 其他
8. 全球質子幫浦阻斷劑市場，依劑型分類，2020-2032 年（十億美元）
- 醫院藥房
- 零售藥局
- 網路藥局
9. 2020 年至 2032 年全球質子幫浦阻斷劑市場（按地區分類）（十億美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第10章 競爭格局
- 公司簡介
- AstraZeneca
- Pfizer
- Takeda Pharmaceutical Company Limited
- Novartis AG
- Procter &Gamble
- Johnson &Johnson
- GlaxoSmithKline plc
- Bayer AG
- Eisai Co., Ltd.
- Merck &Co., Inc.
- Dr. Reddy's Laboratories Ltd.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Sun Pharmaceutical Industries Ltd.
- Allergan, Inc.
- Cadila Pharmaceuticals
- Daiichi Sankyo Company, Limited
- Perrigo Company PLC.
第 11 章 分析師建議
- 機會
- 分析師觀點
- Coherent Opportunity Map
第 12 章參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI4225
Global Proton Pump Inhibitors Market is estimated to be valued at USD 4.02 Bn in 2025 and is expected to reach USD 5.90 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4.02 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.60% | 2032 Value Projection: | USD 5.90 Bn |
Figure. Proton Pump Inhibitors Market Share (%), By Region 2025
Proton pump inhibitors (PPIs) are a group of medicines that work by reducing the amount of acid produced in the stomach. PPIs are commonly used to treat acid reflux, ulcers, and inflammation of the esophagus. These work by blocking the action of the proton pump, an enzyme on the surface of gastric parietal cells. This enzyme is responsible for transportation of ions that aid in the production of hydrochloric acid in the stomach. By inhibiting this pump, PPIs decrease acid production and offer relief from conditions caused by excess stomach acid. Growing prevalence of acid related diseases, increasing aging population suffering from such diseases, rising healthcare expenditure can drive the global proton pump inhibitors market growth in the near future.
Market Dynamics:
Rising prevalence of acid-related diseases such as peptic ulcer disease and gastroesophageal reflux disease (GERD) around the world can drive the global proton pump inhibitors market growth. GERD has become highly common worldwide due to changing dietary patterns and lifestyle changes. According to some estimates, GERD affects over 20% of the population in North America. Proton pump inhibitors are first line treatment for GERD patients. Growing geriatric population can also drive the market growth as older people are more prone to acid-related disorders. However, side effects associated with long-term PPI usage such as kidney problems, bone fractures, pneumonia, and interference with absorption of nutrients can hamper the market growth. Growing awareness regarding digestive health and rising healthcare expenditure in emerging nations can offer opportunities for the market players.
Key Features of the Study:
- This report provides in-depth analysis of the global proton pump inhibitors market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global proton pump inhibitors market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AstraZeneca, Pfizer, Johnson and Johnson, and Bayer
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global proton pump inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global proton pump inhibitors market
Detailed Segmentation-
- By Type
- Omeprazole
- Pantaprazole
- Rabeprazole
- Dexlansoprazole
- lansoprazole
- Others
- By Disease Indication
- Ulcers
- Gastroesophageal Reflux Disease
- Others
- By Dosage Form
- Tablet
- Capsules
- Injection
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- AstraZeneca
- Pfizer
- Takeda Pharmaceutical Company Limited
- Novartis AG
- Procter & Gamble
- Johnson & Johnson
- GlaxoSmithKline plc
- Bayer AG
- Eisai Co., Ltd.
- Merck & Co., Inc.
- Reddy's Laboratories Ltd.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
- Allergan, Inc.
- Cadila Pharmaceuticals
- Daiichi Sankyo Company, Limited
- Perrigo Company PLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Proton Pump Inhibitors Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Proton Pump Inhibitors Market, By Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Omeprazole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pantaprazole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rabeprazole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dexlansoprazole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lansoprazole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Proton Pump Inhibitors Market, By Disease Indication, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Ulcers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gastroesophageal Reflux Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Proton Pump Inhibitors Market, By Dosage Form, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Tablet
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Capsules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Proton Pump Inhibitors Market, By Dosage Form, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Proton Pump Inhibitors Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- AstraZeneca
- Company Highlights
- Disease Indication Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer
- Company Highlights
- Disease Indication Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Novartis AG
- Procter & Gamble
- Johnson & Johnson
- GlaxoSmithKline plc
- Bayer AG
- Eisai Co., Ltd.
- Merck & Co., Inc.
- Dr. Reddy's Laboratories Ltd.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
- Allergan, Inc.
- Cadila Pharmaceuticals
- Daiichi Sankyo Company, Limited
- Perrigo Company PLC.
- AstraZeneca
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. Reference and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
質子幫浦阻斷劑的市場規模、佔有率和成長分析（按藥物類型、給藥途徑、劑型、處方藥、適應症和地區）：產業預測（2024-2031）
質子幫浦抑制劑市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2024-2034 年